Products

Our products

The trifunctional antibody CATUVAB® is based on our proprietary ABCR-Technology. CATUVAB causes EpCAM-positive tumor cells and immune cells to aggregate. The resulting aggregates are physically removed during the mechanical autotransfusion (MAT) process. CATUVAB® can be used, for example, with MAT devices from Fresenius Kabi, Haemonetics, or LivaNova.